DIAH

DIAH 2026

19 – 21 May 2026 | Bruges, Belgium

ProductUpdated on 5 May 2026

ADStem - canine stem cells for osteoarthritis

Endre Kiss-Toth

Founder, CEO at StemcellX Limited

Sheffield, United Kingdom

About

We are completing the submission of our Regulatory Dossier in Europe and the UK in 2026 and are looking to engage with prospective partners to bring our innovative treatments to the market, using our purpose built and certified GMP mass-production site.

We are interested in discussing partnerships in three areas:

  • investment to finance market entry/scaling

  • licencing our product for markets, primarily outside of the EU and UK

  • distributing our product in the EU and UK.

Looking for

  • Distribution Partner
  • Commercial Partner
  • Strategic Partner
  • Licensing Partner
  • Investor

Applies to

  • Animal Health Biotechnology
  • Veterinary Therapeutics

Organisation

StemcellX Limited

Sheffield, United Kingdom

Similar opportunities